FeesSafety
Pluang+

TETRA posts highest Q3 revenue in a decade with $168M, driven by strong international and industrial chemical sales.

Company Fundamentals
03 Nov 2026, 00:00 WIB
PRNewsWire
View Source
Bullish
TETRA posts highest Q3 revenue in a decade with $168M, driven by strong international and industrial chemical sales.

TETRA Technologies reported its highest third-quarter revenue in ten years at $168 million, a 10% increase year-over-year, supported by strong international sales and growth in industrial chemicals. Adjusted EBITDA reached $25.1 million, marking the second-best Q3 performance in a decade. The company is advancing its Arkansas bromine plant project on schedule and expects continued growth in 2027, with double-digit revenue and EBITDA increases forecasted. TETRA also highlighted progress in its water treatment technology and expanded international market presence, signaling robust future prospects.

TETRA Technologies' third-quarter 2026 results are reported here with Pluang's Energy sector data as context. As of Nov 03, 2026 04:11 WIB, out of 79 priced Energy-sector US stocks tradable on Pluang, 14 rose and 65 fell. Notable movers include Kosmos Energy Ltd. Common Shares (KOS) at USD 2.47 with a 1-day change of -13.33%, Liberty Energy Inc. Class A common stock (LBRT) at USD 14.71 with a 1-day change of -12.83% and 100% sell order activity, and Venture Global Inc. Class A common stock (VG) at USD 12.94 with a 1-day change of -12.51%. The most notable figure is the 100% sell order activity for LBRT.

More News

Zentalis grants 136,000 stock options to new hires under Nasdaq inducement rule

Zentalis grants 136,000 stock options to new hires under Nasdaq inducement rule

Zentalis Pharmaceuticals awarded 136,000 non-qualified stock options to four newly hired employees as an inducement to join the company, under Nasdaq Listing Rule 5635(c)(4). The options have an exercise price of $1.85, matching the stock's closing p...

Company Fundamentals
Neutral
28 minutes ago
Dianthus Therapeutics grants stock options to new hires under Nasdaq inducement rule

Dianthus Therapeutics grants stock options to new hires under Nasdaq inducement rule

Dianthus Therapeutics, a clinical-stage biotech company, granted stock options to three new non-executive employees as inducements for joining the company. The options cover 26,000 shares at an exercise price of $82.25, vesting over four years. This ...

Company Fundamentals
Neutral
28 minutes ago
Federal Home Loan Bank of Atlanta elects new directors and appoints 2027 Chair and Vice Chair.

Federal Home Loan Bank of Atlanta elects new directors and appoints 2027 Chair and Vice Chair.

The Federal Home Loan Bank of Atlanta announced the election of three new member directors and the re-election of one independent director to its board for 2026. Suzanne DeFerie was named Chair and Kathy McKinney Vice Chair for 2027, ensuring experie...

Neutral
2 hours ago
Vireo Growth secures DEA registrations for all 41 Florida medical cannabis dispensaries

Vireo Growth secures DEA registrations for all 41 Florida medical cannabis dispensaries

Vireo Growth Inc. has received federal DEA registrations for all 41 of its state-licensed medical cannabis dispensaries in Florida, marking a key regulatory milestone under the new Schedule III framework. This federal recognition supports Vireo's ope...

Market News
Bullish
5 hours ago
XRP faces a potential sharp move as Bollinger Bands squeeze tightest since August 2026.

XRP faces a potential sharp move as Bollinger Bands squeeze tightest since August 2026.

XRP's price is currently in a tight trading range with Bollinger Bands squeezed to their narrowest since August 2026, signaling a possible sharp price move soon. Historically, a similar squeeze led to a 71% rally in three days, but the direction rema...

Technical Signals
Neutral
5 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App